
Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
Keywords: AL, activation loop; ALCL, anaplastic large-cell lymphoma; C-spine, catalytic spine; CRC, colorectal cancer; D, distribution coefficient; DLBCL, diffuse large B-cell lymphoma; EGFR, epidermal growth factor receptor; HGF/SF, hepatocyte growth factor/scatte